Health Care/Hospital
Metabolon Launches New Liver Fibrosis and Kidney Function Discovery Panels to Reveal Disease Mechanisms and Facilitate Research
Metabolon's newest panels help academic and commercial researchers reveal complex biological insights about liver fibrosis and kidney dysfunction MORRISVILLE, N.C., Oct. 12, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of lif...
2023-10-12 19:57
1319
Scott's and 99Speedmart Join Forces to Launch Donation Campaign to Serve Underprivileged Children's Nutritional Needs
* One-month BUY1DONATE1 campaign to be rolled out nationwide, enabling anyone to take part in giving back * Donations of Scott's products to supplement the nutritional needs of 5,000 underprivileged children KUALA LUMPUR, Malaysia, Oct. 12, 2023 /PRNewswire/ -- Scott's, the market leader in t...
2023-10-12 18:56
1713
Neoss® Group receives EU Medical Device Regulation (MDR) certifications for implants and abutments
ZÜRICH, Oct. 12, 2023 /PRNewswire/ -- Neoss Group, a leading innovator in dental implant solutions, is proud to announce that it has received EU Medical Device Regulation (MDR) certification by its Notified Body, the BSI Group, the Netherlands B.V. for its implants and abutments. This certificati...
2023-10-12 18:34
1354
Prestigious World Congress of Neurology Returns In-Person to Convene World-Class Researchers in Montreal
MONTREAL, Oct. 12, 2023 /PRNewswire/ -- The World Federation of Neurology (WFN) and the Canadian Neurological Society (CNS) will host theXXVI World Congress of Neurology (WCN) in Montreal, Canada, from October 15 to 19, 2023. WCN is a major, biennial conference where world-class neurologists and ...
2023-10-12 18:00
1368
Saving on Health Insurance in Hong Kong with NowCompare.com.hk
HONG KONG, Oct. 11, 2023 /PRNewswire/ -- Health insurance is a critical aspect of financial planning, ensuring that individuals and families have access to quality healthcare without the burden of exorbitant medical expenses. InHong Kong, where the cost of healthcare can be quite high, finding th...
2023-10-12 14:38
1442
ALLORION THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN PHASE 1/2 STUDY OF ARTS-021, A POTENTIAL BEST IN CLASS CDK2 INHIBITOR, FOR ADVANCED OR METASTATIC SOLID TUMORS
NATICK, Mass., Oct. 12, 2023 /PRNewswire/ -- Allorion Therapeutics (Allorion), a clinical-stage biotechnology company dedicated to the discovery and development of next-generation targeted drugs for cancer and autoimmune diseases, announced today the dosing of its first patient in the Phase 1/2 ...
2023-10-12 10:37
1422
Suvoda Introduces Advanced Drug Optimization For IRT to Improve Accuracy of Clinical Trial Drug Supply Management
Greater Control Over Drug Supply Management Helps Sponsors Reduce Costs and Carbon Footprint PHILADELPHIA, Oct. 12, 2023 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system (CNS), an...
2023-10-12 09:00
1638
Gencurix Receives Australian Government Approval for Droplex POLE Mutation Test
SEOUL, South Korea, Oct. 12, 2023 /PRNewswire/ -- Gencurix
2023-10-12 06:00
1721
CSL Signs Renewable-Linked Power Purchase Agreement with AGL to Supply Electricity to Australian Manufacturing Sites
MELBOURNE, Australia, Oct. 12, 2023 /PRNewswire/ -- Global biotechnology leader CSL (ASX: CSL; USOTC: CSLLY) announced today thatit has signed a Renewable-Linked Power Purchase Agreement (PPA) with Australian energy provider, AGL.AGL was awarded the contract after an extensive review of the ener...
2023-10-12 05:00
3277
KHB Becomes First Chinese Company to Obtain EU Class D IVDR Certification for Its Rapid Test HIV Colloidal Gold Diagnostic Kit
SHANGHAI, Oct. 11, 2023 /PRNewswire/ -- Shanghai Kehua Bio-engineering
2023-10-11 16:27
2085
Smith+Nephew opens new state-of-the-art surgical innovation and training centre in the heart of Munich
LONDON, Oct. 11, 2023 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company specialising in orthopaedics, advanced wound management and sports medicine, is pleased to announce the opening of the purpose-built Smith+Nephew Academy Munich, a new centre for surgica...
2023-10-11 14:00
3145
EQT to acquire VetPartners, the leading provider of veterinary and animal health services in Australia and New Zealand
* EQT to acquire VetPartners, the leading provider of veterinary and animal health services across a network of 267 general practice clinics and specialty hospitals inAustralia and New Zealand * With a community of more than 1,300 highly skilled vets and over 3,000 nurses and cli...
2023-10-11 12:21
1749
Ascletis Announces Poster Presentation of Phase II Study Topline Results of FASN Inhibitor ASC40 for Treatment of Acne at EADV Congress 2023
HANGZHOU and SHAOXING, China, Oct. 11, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672, "Ascletis") today announces the poster presentation of Phase II study topline results of ASC40, a first-in-class fatty acid synthase (FASN) inhibitor for treatment of acne, at the European Academy of Der...
2023-10-11 08:10
1765
VISTA Eye Specialist Achieves International Recognition at European Congress
PETALING JAYA, Malaysia, Oct. 11, 2023 /PRNewswire/ -- Last September, VISTA Eye Specialist proudly marked its presence at the prestigious European Society of Cataract and Refractive Surgery (ESCRS) Symposium and Congress inVienna, Austria. This event, the second participation since the onset of ...
2023-10-11 08:00
1720
JUNG KWAN JANG launches student-specialized brand I.PASS for physical strength, immunity, and memory all at once
- The essential item that Korean parents with high enthusiasm over education provide for their children SEOUL, South Korea, Oct. 11, 2023 /PRNewswire/ -- I.PASS, a student-specialized brand that was renewed and launched through JUNG KWAN JANG red ginseng of KGC (Korea Ginseng Corp.), is a health...
2023-10-11 07:00
2046
EADV Congress: Non-melanoma skin cancer killing more people than melanoma, new study finds
BERLIN, Oct. 11, 2023 /PRNewswire/ -- Non-melanoma skin cancer (NMSC) is causing a greater number of global deaths than melanoma, the more serious form of skin cancer, a new study presented today at the EADV Congress 2023 has found. Researchers also believe that NMSC is underreported and that the...
2023-10-11 06:01
1578
SAFETYscan47: A Valuable Component in Revolutionizing Chemical Risk Assessments for Global Health and Safety
SAN DIEGO, Oct. 10, 2023 /PRNewswire/ -- Eurofins Discovery, an industry-leading provider of products and services for drug discovery research, today announced its SAFETYscan®47 platform as a New Approach Methodology (NAM), part of a standardized framework aiming to revolutionize chemical risk a...
2023-10-10 23:10
1661
Novel classification of allergic disorders published by the European Academy of Allergy and Clinical Immunology: SIAF
Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper published in 'Allergy' DAVOS, Switzerland, Oct. 10, 2023 /PRNewswire/ -- The revision of the current allergic disease nomenclature based on symptoms and organ dysfunction has been l...
2023-10-10 19:10
1239
Gates Foundation Celebrates 20 Years of "Grand Challenges" With New Investments and a Call to Make R&D Breakthroughs Available More Quickly and Equitably
Commitments focus on advancing equitable access to artificial intelligence (AI) and vaccines,and catalyzing innovations that address women's health SEATTLE and DAKAR, Senegal, Oct. 10, 2023 /PRNewswire/ -- A slate of new initiatives to support locally led innovation was announced today inDakar b...
2023-10-10 18:30
1337
Scorpion Therapeutics and Pierre Fabre Laboratories Announce First Patient Dosed in Phase 1/2 Clinical Trial of STX-721, a Mutant-Selective EGFR Exon 20 Inhibitor for the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer
-- STX-721 is characterized by high selectivity and a potentially best-in-class profile -- -- Scorpion's second program to enter clinical development this year -- -- One of two EGFR programs being developed with Pierre Fabre Laboratories -- BOSTON and CASTRES, France, Oct. 10, 2023 /PRNewswire/...
2023-10-10 18:00
1376
Week's Top Stories
Most Reposted
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 318 media titles]
2024-05-15 12:00
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 302 media titles]
2024-05-16 15:00
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 274 media titles]
2024-05-16 09:39
Central Embassy, celebrates its 10th anniversary with a world-class immersive presentation--the first of its kind in Thailand--by renowned artist Daniel Arsham
[Picked up by 272 media titles]
2024-05-10 15:20
Where does China's production capacity come from?
[Picked up by 258 media titles]
2024-05-10 12:01Most Read
Huawei Launching the All-Scenario Smart Telecom Power Solutions
2024-05-11 17:52
8907
Central Embassy, celebrates its 10th anniversary with a world-class immersive presentation--the first of its kind in Thailand--by renowned artist Daniel Arsham
2024-05-10 15:20
8266
Where does China's production capacity come from?
2024-05-10 12:01
8102
China Jo-Jo Drugstores Announces $2.74 Million Registered Direct Offering
2024-05-10 21:20
4991